Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8(+) T cell exhaustion.

Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8(+) T cell exhaustion.
复制标题

NADase CD38在调节CD8(+) T细胞衰竭中的细胞自主作用的功能评估。

DOI:
10.1016/j.isci.2022.104347
复制
发表时间:
2022-05-20
期刊:
影响因子:
5.8
通讯作者:
Zhang, Lianjun
Zhang, Lianjun
中科院分区:
综合性期刊2区
文献类型:
--
作者:
Ma, Kaili;Sun, Lina;Shen, Mingjing;Zhang, Xin;Xiao, Zhen;Wang, Jiajia;Liu, Xiaowei;Jiang, Kanqiu;Qin, F. Xiao-Feng;Guo, Feng;Zhang, Baojun;Zhang, Lianjun

文献摘要

参考文献

相似文献

效应功能有限的耗竭 CD8+ T 细胞和多种共抑制受体的高表达是阻碍抗肿瘤免疫的主要障碍之一。 NADase CD38 作为 CD8+ T 细胞耗竭的生物标志物受到了相当大的关注,但尚不清楚增加的 CD38 是否会直接促进 T 细胞功能障碍。在这里,我们令人惊讶地发现,尽管 Cd38 缺乏在体外部分逆转了 NAD+ 降解和 T 细胞功能障碍,但肿瘤中过继转移的 CD8+ T 细胞的终末分化不受 CD38 缺乏或过度表达的影响。监测动态 NAD+ 水平表明,肿瘤浸润的 WT 细胞和 Cd38−/− OT-1 细胞之间的 NAD+ 水平相当。因此,我们的结果表明,NAD+ 减少与 T 细胞功能障碍相关,但 CD38 缺乏不足以挽救肿瘤浸润的 CD8+ T 细胞中的 NAD+,并且无法提高抗肿瘤 T 细胞治疗的疗效。通过持续的抗原刺激,CD8+ T 细胞上的 CD38 上调 CD38 的缺失可部分逆转 NAD+ 降解和体外 T 细胞功能障碍 CD38 缺乏无法阻止或延迟肿瘤内 CD8+ T 细胞的耗竭 肿瘤浸润 T 细胞中的 NAD+ 水平受 CD38 和其他 NAD 酶的调节细胞生物学;癌症
Exhausted CD8+ T cells with limited effector functions and high expression of multiple co-inhibitory receptors are one of the main barriers hindering antitumor immunity. The NADase CD38 has received considerable attention as a biomarker of CD8+ T cell exhaustion, but it remains unclear whether the increased CD38 directly promotes T cell dysfunctionality. Here, we surprisingly found that although Cd38 deficiency partially reverses NAD+ degradation and T cell dysfunction in vitro, the terminal exhausted differentiation of adoptively transferred CD8+ T cells in tumor is not impacted by either deficiency or overexpression of CD38. Monitoring the dynamic NAD+ levels shows that NAD+ levels are comparable between tumor infiltrated WT and Cd38−/− OT-1 cells. Therefore, our results suggest that decreased NAD+ are correlated with T cell dysfunction, but deficiency of CD38 is not enough for rescuing NAD+ in tumor infiltrated CD8+ T cells and fails to increase the efficacy of antitumor T cell therapy. CD38 is upregulated on CD8+ T cells by persistent antigen stimulation Deletion of CD38 partially reverses NAD+ degradation and T cell dysfunction in vitro CD38 deficiency fails to prevent or delay CD8+ T cell exhaustion within tumor NAD+ levels in tumor infiltrated T cells are regulated by CD38 and other NADases Immunology; Cell biology; Cancer
DOI: 10.1084/jem.20142237
发表时间: 2015-06-29
期刊: The Journal of experimental medicine
影响因子: --
作者:
Odorizzi PM;Pauken KE;Paley MA;Sharpe A;Wherry EJ
通讯作者: Wherry EJ
DOI: 10.1038/s42255-020-00298-z
发表时间: 2020-11
期刊: Nature metabolism
影响因子: 20.8
作者:
Chini CCS;Peclat TR;Warner GM;Kashyap S;Espindola-Netto JM;de Oliveira GC;Gomez LS;Hogan KA;Tarragó MG;Puranik AS;Agorrody G;Thompson KL;Dang K;Clarke S;Childs BG;Kanamori KS;Witte MA;Vidal P;Kirkland AL;De Cecco M;Chellappa K;McReynolds MR;Jankowski C;Tchkonia T;Kirkland JL;Sedivy JM;van Deursen JM;Baker DJ;van Schooten W;Rabinowitz JD;Baur JA;Chini EN
通讯作者: Chini EN
DOI: 10.1038/s41586-019-1325-x
发表时间: 2019-07-11
期刊: NATURE
影响因子: 64.8
作者:
Khan, Omar;Giles, Josephine R.;Wherry, E. John
通讯作者: Wherry, E. John
从头表观遗传程序抑制PD-1封锁介导的T细胞再生。
DOI: 10.1016/j.cell.2017.06.007
发表时间: 2017-06-29
期刊: Cell
影响因子: 64.5
作者:
Ghoneim HE;Fan Y;Moustaki A;Abdelsamed HA;Dash P;Dogra P;Carter R;Awad W;Neale G;Thomas PG;Youngblood B
通讯作者: Youngblood B
DOI: 10.1186/s40425-017-0235-4
发表时间: 2017
影响因子: 10.9
作者:
Sckisel GD;Mirsoian A;Minnar CM;Crittenden M;Curti B;Chen JQ;Blazar BR;Borowsky AD;Monjazeb AM;Murphy WJ
通讯作者: Murphy WJ